QuickVue Influenza A + B Test Field Study
NCT03417869 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 1381
Last updated 2018-03-20
Summary
Demonstrate improved clinical performance of visually read QuickVue Influenza A+B test.
Conditions
- Influenza A, Influenza B
Interventions
- DEVICE
-
QuickVue Influenza A+B
Rapid diagnostic test with IVD, QuickVue Influenza A+B
Sponsors & Collaborators
-
Quidel Corporation
lead INDUSTRY
Eligibility
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2017-02-16
- Primary Completion
- 2018-02-01
- Completion
- 2018-02-01
- FDA Device
- Yes
Countries
- United States
Study Locations
More Related Trials
-
Evaluation of COVID-19 and Flu A/B 3 in 1 Combo Rapid Test
NCT07190131 ·Status: COMPLETED
-
A Study to Evaluate the Safety, Tolerability, and Immunogenicity of a Combined Modified RNA Vaccine Candidate Against COVID-19 and Influenza.
NCT06178991 ·Status: COMPLETED ·Phase: PHASE3
-
Validation of the Ellume® Respirio Flu Test and the Ellume® eLab Flu Test for the Rapid Identification of Influenza A/B
NCT02767414 ·Status: COMPLETED ·Phase: NA
-
H5N1 Mix and Match With MF59
NCT01317745 ·Status: COMPLETED ·Phase: PHASE1
-
Safety, Tolerability and Immunogenicity of Two Doses of Adjuvanted Monovalent Influenza Vaccine Administered to Healthy Adult and Elderly Subjects
NCT00841763 ·Status: COMPLETED ·Phase: PHASE3
-
Assess Safety and Immunogenicity of A/H5 Inactivated Monovalent Influenza Vaccines at Different Antigen Dose Levels Adjuvanted With AS03 or MF59
NCT06560151 ·Status: COMPLETED ·Phase: PHASE2
-
Clinical Trial to Evaluate the Safety and Immunogenicity of Quadrivalent Influenza Vaccine (7.5μg/0.25ml)
NCT03859141 ·Status: COMPLETED ·Phase: PHASE3
-
Long-term Observation of Hemagglutinin and Neuraminidase Inhibition Antibody Titers After Influenza Challenge
NCT02511002 ·Status: ENROLLING_BY_INVITATION
-
Influenza A+B Test Kit Performance Study
NCT03895268 ·Status: UNKNOWN
-
Clinical Characteristics and Outcomes in Patients Diagnosed With Novel Influenza A (H1N1)
NCT01024673 ·Status: COMPLETED
-
Influenza Diagnosis, Treatment and Surveillance With Xpert Flu
NCT01947049 ·Status: COMPLETED ·Phase: NA
-
A Study To Learn About The Study Vaccine (Called Self-Amplifying Ribonucleic Acid (RNA)) For The Prevention of Influenza
NCT05227001 ·Status: COMPLETED ·Phase: PHASE1
-
Clinical Study for Safety and Immunogenicity Study of Influenza Vaccine
NCT01617239 ·Status: COMPLETED ·Phase: PHASE1
-
Quadrivalent Influenza VLP Vaccine Dose Ranging Study in Young Adults
NCT02307851 ·Status: COMPLETED ·Phase: PHASE2
-
A Study to Investigate the Immunogenicity, Reactogenicity, and Safety of mRNA-1083 (Influenza and COVID-19) Vaccine in Adults ≥18 to <65 Years of Age
NCT06864143 ·Status: COMPLETED ·Phase: PHASE2
-
PET-CT Scans in Healthy Volunteers After Flu Vaccination
NCT00769002 ·Status: TERMINATED ·Phase: NA
-
Safety and Immunogenicity of a Monovalent Inactivated Influenza H3N2 Variant (H3N2v) Vaccine in Adult and Elderly Populations
NCT01746082 ·Status: COMPLETED ·Phase: PHASE2
-
Safety and Immunogenicity of Two Doses of H5N1 Influenza Vaccine in Elderly Subjects
NCT01766921 ·Status: COMPLETED ·Phase: PHASE2
-
Open-label Study to Assess Immunogenicity and Safety of a Vaccine Enhancement Patch When Administered With 2 Doses of H5N1 Vaccine
NCT01353534 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Safety, Tolerability, and Immunogenicity of the Adjuvanted Trivalent Subunit Influenza Vaccine and the Non-Adjuvanted Trivalent Subunit Influenza Vaccine Compared to the Non-Adjuvanted Trivalent Split Influenza Vaccine in Children 6 to < 72 Months of Age
NCT01346592 ·Status: COMPLETED ·Phase: PHASE3
-
Safety and Immunogenicity of H5N1 Adjuvanted, Inactivated, Split-Virion Pandemic Influenza Vaccine in Healthy Adults
NCT00457509 ·Status: COMPLETED ·Phase: PHASE1
-
Evaluation of Performance of the LumiraDx Influenza A/B + RSV Test at POC Testing Sites
NCT04288921 ·Status: UNKNOWN ·Phase: NA
-
Pivotal, Multicenter, Observer-Blind, Randomized Study of Influenza A (H1N1)2009 Monovalent Subunit Vaccine With and Without Adjuvant in Children Ages 6 to <36 Months
NCT00996307 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
A Study of mRNA-based Influenza and SARS-CoV-2 (COVID-19) Multi-component Vaccines in Healthy Adults
NCT05827926 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Safety and Immunogenicity of Different Formulations of an MF59-Adjuvanted Influenza Vaccine in Older Adults
NCT04782323 ·Status: COMPLETED ·Phase: PHASE2